KINUF yields 1.70% · PFE yields 6.13%● Live data
📍 KINUF pulled ahead of the other in Year 1
Combined, KINUF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KINUF + PFE for your $10,000?
Kintetsu Group Holdings Co.,Ltd. engages in the transportation, real estate, distribution, hotel, and leisure businesses in Japan and internationally. The company offers railway, bus and taxi, logistics, marine, and other transportation services. It is also involved in the sale, leasing, and renovation of real estate properties; and solar and agricultural businesses. In addition, the company operates department stores; stores; convenience stores, cafes, drug stores, general merchandise stores, supermarkets, etc.; restaurants and others in the service and parking areas of expressways; and hotels under the Miyako Hotels & Resorts brand, as well as resorts and leisure facilities. Further, it engages in the tourism, travel, manufacturing and construction, and other service businesses. The company was formerly known as Kintetsu Corporation and changed its name to Kintetsu Group Holdings Co.,Ltd. in April 2015. Kintetsu Group Holdings Co.,Ltd. was founded in 1910 and is headquartered in Osaka, Japan.
Full KINUF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.